(1)
Nwizu, C. R.; Nnadi, C. O.; Igboasoiyi, A. C. Structure-Based Virtual Screening Identifies Ritobegron and Resveratrol As Dual Inhibitors of NMDA and PTP-1B for Alzheimer’s Disease Therapy. TJPPS 2026, 5, 468-474.